INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO)

CUSIP: 45773H409

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
66,777,963
Total 13F shares
8,566,045
Share change
+425,859
Total reported value
$49,511,575
Put/Call ratio
72%
Price per share
$5.78
Number of holders
95
Value change
+$2,096,827
Number of buys
41
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Deep Track Capital, LP
13F
Company
3.1%
2,066,720
$16,699,098 30 Jun 2024
13F
BlackRock Finance, Inc.
13F
Company
2.6%
1,706,420
$13,787,875 30 Jun 2024
13F
VANGUARD GROUP INC
13F
Company
2.4%
1,581,571
$12,779,093 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.87%
582,798
$4,709,634 30 Jun 2024
13F
STATE STREET CORP
13F
Company
0.66%
439,248
$3,549,124 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.61%
410,566
$3,317,373 30 Jun 2024
13F
Jong Joseph Kim
3/4/5
Chief Executive Officer, Director
mixed-class rows
3,113,086
mixed-class rows
$2,451,149 11 Mar 2022
MORGAN STANLEY
13F
Company
0.16%
103,706
$837,946 30 Jun 2024
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.15%
99,991
$807,927 30 Jun 2024
13F
Bank of New York Mellon Corp
13F
Company
0.12%
81,835
$661,227 30 Jun 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.12%
79,279
$640,574 30 Jun 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.11%
74,858
$604,853 30 Jun 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.11%
71,099
$574,480 30 Jun 2024
13F
NORTHERN TRUST CORP
13F
Company
0.09%
61,112
$493,785 30 Jun 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.07%
46,491
$375,647 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.06%
42,401
$342,600 30 Jun 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.06%
38,494
$311,022 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
38,357
$309,925 30 Jun 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.06%
37,598
$303,792 30 Jun 2024
13F
Green Alpha Advisors, LLC
13F
Company
0.05%
33,085
$267,327 30 Jun 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.05%
31,565
$255,045 30 Jun 2024
13F
UBS Group AG
13F
Company
0.04%
27,391
$221,319 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.04%
25,772
$208,238 30 Jun 2024
13F
Alpine Global Management, LLC
13F
Company
0.04%
24,916
$201,321 30 Jun 2024
13F
CORNERCAP INVESTMENT COUNSEL INC
13F
Company
0.03%
22,712
$183,513 30 Jun 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.03%
22,031
$178,010 30 Jun 2024
13F
Jump Financial, LLC
13F
Company
0.03%
21,756
$175,788 30 Jun 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.03%
20,652
$167,000 30 Jun 2024
13F
Corton Capital Inc.
13F
Company
0.03%
20,283
$163,887 30 Jun 2024
13F
Walleye Capital LLC
13F
Company
0.03%
18,758
$151,565 30 Jun 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.02%
16,497
$133,296 30 Jun 2024
13F
GROUP ONE TRADING LLC
13F
Company
0.02%
15,571
$125,814 30 Jun 2024
13F
WOLVERINE TRADING, LLC
13F
Company
0.02%
14,807
$119,641 30 Jun 2024
13F
Corebridge Financial, Inc.
13F
Company
0.02%
13,662
$110,526 30 Jun 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
13,117
$105,986 30 Jun 2024
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
12,900
$104,232 30 Jun 2024
13F
Graham Capital Management, L.P.
13F
Company
0.02%
12,712
$102,713 30 Jun 2024
13F
Invesco Ltd.
13F
Company
0.02%
11,495
$92,880 30 Jun 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
11,296
$91,272 30 Jun 2024
13F
SIGNATURE ESTATE & INVESTMENT ADVISORS LLC
13F
Company
0.02%
10,876
$87,878 30 Jun 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
10,169
$82,166 30 Jun 2024
13F
Keystone Financial Group
13F
Company
0.02%
10,088
$81,512 30 Jun 2024
13F
Prime Capital Investment Advisors, LLC
13F
Company
0.02%
10,036
$81,091 30 Jun 2024
13F
BARCLAYS PLC
13F
Company
0.01%
8,887
$71,807 30 Jun 2024
13F
MetLife Investment Management, LLC
13F
Company
0.01%
6,621
$53,498 30 Jun 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
5,884
$47,543 30 Jun 2024
13F
FMR LLC
13F
Company
0.01%
5,799
$46,852 30 Jun 2024
13F
CITIGROUP INC
13F
Company
0.01%
5,708
$46,121 30 Jun 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
3,501
$28,000 30 Jun 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0%
3,054
$24,000 30 Jun 2024
13F

Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) as of Q3 2024

As of 30 Sep 2024, INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,566,045 shares. The largest 10 holders included BlackRock, Inc., Deep Track Capital, LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, DIMENSIONAL FUND ADVISORS LP, GMT CAPITAL CORP, and MORGAN STANLEY. This page lists 95 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
92
Q3 2024 holders
95
Holder diff
3
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.